Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung CancerValsamo Anagnostou, Victor E. Velculescu, Kristen Rodgers et al.|Cancer Discovery|2016Cited by 897
Frequency of homozygous deletion at p16/CDKN2 in primary human tumoursPaul Cairns, David Sidransky, Thomas J. Polascik et al.|Nature Genetics|1995Cited by 646
Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non–Small Cell Lung CancerValsamo Anagnostou, Victor E. Velculescu, Patrick M. Forde et al.|Cancer Research|2018Cited by 313
Molecular markers in ductal carcinoma in situ of the breast.Dale Porter, Kornélia Polyák, Jaana Lahti‐Domenici et al.|PubMed|2003Cited by 261
A neural survival factor is a candidate oncogene in breast cancerDale Porter, Kornélia Polyák, Stanislawa Weremowicz et al.|Proceedings of the National Academy of Sciences|2003Cited by 132